EMA Endorses COVID-19 Antibody Therapies From Regeneron-Roche, Celltrion

November 11, 2021

The European Medicines Agency (EMA) has given the thumbs up to two COVID-19 antibody therapies from Regeneron-Roche and Celltrion Healthcare, paving the way for imminent approval by the European Commission.
Source: Drug Industry Daily

Posted in Drug Industry Daily